Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers

Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mackenzie E. Fowler, Dario A. Marotta, Richard E. Kennedy, Adam Gerstenecker, Meredith Gammon, Kristen Triebel
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3a448e66da164c43831ad3380f57fd9a
record_format dspace
spelling oai:doaj.org-article:3a448e66da164c43831ad3380f57fd9a2021-11-25T06:06:36ZReliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers2162-327910.1002/brb3.2303https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a2021-11-01T00:00:00Zhttps://doi.org/10.1002/brb3.2303https://doaj.org/toc/2162-3279Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sectional study of metastatic cancer patients at a large academic medical center. Across all standards of MDC, sensitivity, specificity, and reliability using Gwet's AC1 statistic were calculated using the objective measure as the gold standard. Logistic regression was used to evaluate predictors of agreement between the measures across all MDC standards. Results In those with brain metastases, high sensitivity (greater than 0.7), but low specificity was observed for all standards. Poor reliability was observed across all standards. Higher age resulted in higher odds of disagreement for Standard 3 (appreciation) (OR: 1.07, 95% CI: 1.00, 1.15) and Standard 4 (reasoning) (OR: 1.05, 95% CI: 1.00, 1.10). For Standard 3, chemotherapy use and brain metastases compared to other metastases resulted in higher odds of disagreement (Chemotherapy: OR: 5.62, 95% CI: 1.37, 23.09, Brain Metastases: OR: 5.93, 95% CI: 1.28, 27.55). For Standard 5 (understanding), no predictors were associated with disagreement. Conclusions For less cognitively complex standards (e.g., appreciation), self‐report may be more valid and reliable than more cognitively complex standards (e.g., reasoning or understanding). However, overall, MDC self‐report in the current sample is suboptimal. Thus, the need for detailed assessment of MDC, especially when patients are older or used chemotherapy, is indicated. Other studies should be conducted to assess MDC agreement longitudinally.Mackenzie E. FowlerDario A. MarottaRichard E. KennedyAdam GersteneckerMeredith GammonKristen TriebelWileyarticlebrain metastasismedical decision‐making capacitymetastatic cancerpredictorsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain and Behavior, Vol 11, Iss 11, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic brain metastasis
medical decision‐making capacity
metastatic cancer
predictors
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle brain metastasis
medical decision‐making capacity
metastatic cancer
predictors
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Mackenzie E. Fowler
Dario A. Marotta
Richard E. Kennedy
Adam Gerstenecker
Meredith Gammon
Kristen Triebel
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
description Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sectional study of metastatic cancer patients at a large academic medical center. Across all standards of MDC, sensitivity, specificity, and reliability using Gwet's AC1 statistic were calculated using the objective measure as the gold standard. Logistic regression was used to evaluate predictors of agreement between the measures across all MDC standards. Results In those with brain metastases, high sensitivity (greater than 0.7), but low specificity was observed for all standards. Poor reliability was observed across all standards. Higher age resulted in higher odds of disagreement for Standard 3 (appreciation) (OR: 1.07, 95% CI: 1.00, 1.15) and Standard 4 (reasoning) (OR: 1.05, 95% CI: 1.00, 1.10). For Standard 3, chemotherapy use and brain metastases compared to other metastases resulted in higher odds of disagreement (Chemotherapy: OR: 5.62, 95% CI: 1.37, 23.09, Brain Metastases: OR: 5.93, 95% CI: 1.28, 27.55). For Standard 5 (understanding), no predictors were associated with disagreement. Conclusions For less cognitively complex standards (e.g., appreciation), self‐report may be more valid and reliable than more cognitively complex standards (e.g., reasoning or understanding). However, overall, MDC self‐report in the current sample is suboptimal. Thus, the need for detailed assessment of MDC, especially when patients are older or used chemotherapy, is indicated. Other studies should be conducted to assess MDC agreement longitudinally.
format article
author Mackenzie E. Fowler
Dario A. Marotta
Richard E. Kennedy
Adam Gerstenecker
Meredith Gammon
Kristen Triebel
author_facet Mackenzie E. Fowler
Dario A. Marotta
Richard E. Kennedy
Adam Gerstenecker
Meredith Gammon
Kristen Triebel
author_sort Mackenzie E. Fowler
title Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
title_short Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
title_full Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
title_fullStr Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
title_full_unstemmed Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
title_sort reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
publisher Wiley
publishDate 2021
url https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a
work_keys_str_mv AT mackenzieefowler reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
AT darioamarotta reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
AT richardekennedy reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
AT adamgerstenecker reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
AT meredithgammon reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
AT kristentriebel reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers
_version_ 1718414156111020032